Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 963-970 , August 2009

Strategies to Improve Long-Term Outcome in Stage IIIB Inflammatory Breast Cancer: Multimodality Treatment Including Dose-Intensive Induction and High-Dose Chemotherapy

  • Claude Sportès

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • Corresponding Author InformationCorrespondence and reprint requests: Claude Sportès, MD, Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, 10 Center drive, Room 43142, Bethesda, MD 20892-1203.
    • ,
  • Seth M. Steinberg

      Affiliations

    • Biostatistics & Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • David J. Liewehr

      Affiliations

    • Biostatistics & Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Juan Gea-Banacloche

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • David N. Danforth

      Affiliations

    • Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Daniele N. Avila

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Kelly E. Bryant

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Michael C. Krumlauf

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Daniel H. Fowler

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Steven Pavletic

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Nancy M. Hardy

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Michael R. Bishop

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Ronald E. Gress

      Affiliations

    • Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

Received 18 February 2009 ,Accepted 25 April 2009.

  • Image Result

    Survival curves (Kaplan-Meyer) for PFS, EFS, and OS from on-study date.(a) All patients; (b) patients stratified by Her-2 status (P-values of Log rank test are indicated).

    Survival curves (Kaplan-Meyer) for PFS, EFS, and OS from on-study date.(a) All patients; (b) patients stratified by Her-2 status (P-values of Log rank test are indicated).

 Financial disclosure: See acknowledgments on page 969.

PII: S1083-8791(09)00215-8

doi: 10.1016/j.bbmt.2009.04.018

Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 963-970 , August 2009

Article Tools

* Image Usage & Resolution